Skip to main content

Antibody Drug Development Summit Recordings

Hear from experts on the many challenges and solutions in the preclinical drug development pipeline, how to choose the most translationally-relevant preclinical in vivo models to identify promising therapeutic candidates, and how large biopharmaceutical companies use humanized in vivo models as tools to de-risk their antibody drug development pipeline.